Lilly Eli Co (LLY)

06:37 AM

Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop - Benzinga

06:37 AM

03:34 AM

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen - Benzinga

03:34 AM

11:32 AM

Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval - Yahoo

11:32 AM

10:32 AM

European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval - Winnipeg Free Press

10:32 AM

10:31 AM

European committee says Lilly Alzheimer's drug shouldn't get marketing approval - Yahoo Finance

10:31 AM

10:15 AM

Eli Lilly’s Alzheimer’s drug gets thumbs down from EU regulator - Sherwood News

10:15 AM

09:50 AM

Eli Lilly Alzheimer’s Drug Kisunla Fails To Get EU Backing - NDTV Profit

09:50 AM

09:35 AM

Billionaire Ken Fisher’s #2 Low Vol Stock Pick: Eli Lilly & Company (LLY) - Insider Monkey

09:35 AM

08:48 AM

Eli Lilly Alzheimer’s drug fails to win EU nod (LLY:NYSE) - Seeking Alpha

08:48 AM

08:37 AM

EU regulator declines approval for Eli Lilly’s new Alzheimer’s drug - Financial Times

08:37 AM

08:13 AM

Eli Lilly’s Alzheimer’s drug gets thumbs-down from European regulators - STAT

08:13 AM

08:03 AM

Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Bloomberg

08:03 AM

07:55 AM

Eli Lilly Remains Confident In The Safety And Effectiveness Of Donanemab - Marketscreener.com

07:55 AM

07:48 AM

EU regulator rejects Eli Lilly's Alzheimer's drug - Reuters.com

07:48 AM

07:27 AM

Lilly stock dips as Kisunla misses EU approval By Investing.com - Investing.com South Africa

07:27 AM

07:02 AM

Lilly’s statement about the CHMP opinion issued for donanemab - Investors | Eli Lilly and Company

07:02 AM

06:44 AM

Eli Lilly & Co. (LLY) call put ratio 1 call to 1.3 puts - StreetInsider.com

06:44 AM

Mar 27, 2025

Lilly adds Alzheimer's to online offerings - Reuters

Mar 27, 2025

Mar 27, 2025

Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today - Benzinga

Mar 27, 2025

Mar 27, 2025

Eli Lilly Says Michigan AG's Insulin Pricing Probe Is Baseless - Law360

Mar 27, 2025

Mar 27, 2025

Eli Lilly expands LillyDirect to include Alzheimer's resources - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Eli Lilly taps Chicago startup as it expands digital health platform - Crain's Chicago Business

Mar 27, 2025

Mar 27, 2025

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s - Yahoo

Mar 27, 2025

Mar 27, 2025

Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - AOL

Mar 27, 2025

Mar 27, 2025

LillyDirect Platform Expands To Facilitate Access To Alzheimer's Disease Care - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

LillyDirect platform expands to facilitate access to Alzheimer's disease care - Investors | Eli Lilly and Company

Mar 27, 2025

Mar 27, 2025

In a first, Eli Lilly to connect patients to telehealth providers of Alzheimer’s care - STAT

Mar 27, 2025

Mar 27, 2025

Revolutionary Digital Platform Cuts Alzheimer's Care Wait Times from Years to Days - StockTitan

Mar 27, 2025

Mar 26, 2025

Eli Lilly comms head Kathryn Beiser resigns - PR Week

Mar 26, 2025

Mar 26, 2025

Eli Lilly's GLP-1 pill could be the next key in obesity treatment - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Eli Lilly and Company (LLY): One of Two Sigma Investments’ Top Stock Picks - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Eli Lilly (LLY) Stock: Why Analysts See 30% Upside Potential - MoneyCheck

Mar 26, 2025

Mar 26, 2025

Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here - Benzinga

Mar 26, 2025

Mar 26, 2025

Eli Lilly CEO invites job seekers for new Hyderabad tech hub | Exclusive - CNBCTV18

Mar 26, 2025

Mar 26, 2025

Mounjaro: Here Is How Eli Lilly Shares Have Performed Since The Launch Its Own Ozempic - Free Press Journal

Mar 26, 2025

Mar 26, 2025

Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India - Business Today

Mar 26, 2025

Mar 25, 2025

Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks - The Economic Times

Mar 25, 2025

Mar 25, 2025

Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Mar 25, 2025

Mar 25, 2025

Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting - Quantisnow

Mar 25, 2025

Mar 25, 2025

Lilly Announces Details Of Presentations At 2025 American Association For Cancer Research (AACR) Annual Meeting - Marketscreener.com

Mar 25, 2025

Mar 25, 2025

Lilly Unveils Groundbreaking Cancer Drug Pipeline: Dual Phase 1 Programs Target KRAS and SMARCA4 Mutations - StockTitan

Mar 25, 2025

Mar 25, 2025

Global CEO Of Eli Lilly, World’s Pioneer Insulin Manufacturing Company, David Ricks Called On Union Minister Dr. Jitendra Singh To Discuss Strengthening Partnership, With A Focus On Insulin And NCD Therapies As Well As Biomanufacturing. - TRIPURA STAR NEWS

Mar 25, 2025

Mar 25, 2025

Bernstein reiterates Eli Lilly outperform with $1100 target - Investing.com

Mar 25, 2025

Mar 25, 2025

Eli Lilly GC Made Nearly $7.5M In 2024 - Law360

Mar 25, 2025

Mar 25, 2025

Bernstein reiterates Eli Lilly outperform with $1100 target By Investing.com - Investing.com UK

Mar 25, 2025

Mar 25, 2025

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - Quantisnow

Mar 25, 2025

Mar 25, 2025

Novo Nordisk follows Eli Lilly with its own ‘triple-G’ drug - STAT

Mar 25, 2025

Mar 25, 2025

Is Eli Lilly and Company (NYSE:LLY) The Best Stocks to Buy Now For the Long Term? - Insider Monkey

Mar 25, 2025

Mar 24, 2025

Eli Lilly Shares Rise Over 2% After Key Signal - Benzinga

Mar 24, 2025

Mar 24, 2025

UBS maintains Eli Lilly stock Buy rating, $1,100 price target By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

5 Stocks That Could Be The Next Nvidia - Benzinga

Mar 24, 2025

Mar 24, 2025

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer - NBC Philadelphia

Mar 24, 2025

Mar 24, 2025

Eli Lilly’s Mounjaro targets India’s $150 billion weight-loss market amid rising diabetes crisis - CNBCTV18

Mar 24, 2025

Mar 24, 2025

Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped - MSN

Mar 24, 2025